PTPRT loss enhances anti–PD-1 therapy efficacy by regulation of STING pathway in non–small cell lung cancer | Science Translational Medicine

PTPRT deficiency activates STING signaling, reprograms antitumor immune microenvironment, and strengthens efficacy of immune checkpoint inhibitors.